Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.0%

1 terminated out of 33 trials

Success Rate

96.4%

+9.9% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

30%

8 of 27 completed with results

Key Signals

8 with results96% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (10)
Early P 1 (2)
P 1 (9)
P 2 (6)
P 3 (1)
P 4 (2)

Trial Status

Completed27
Unknown4
Withdrawn1
Terminated1

Trial Success Rate

96.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT03423667Phase 2TerminatedPrimary

Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction

NCT04336293Not ApplicableCompletedPrimary

sTMS for Substance Use-disordered Veterans

NCT02563769Phase 1Completed

Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study

NCT00729300Phase 1CompletedPrimary

A Study of the Relationship Between Disulfiram and Cocaine Self-administration.

NCT01211418Not ApplicableCompletedPrimary

Integrative Meditation (IM) for Cocaine Addiction

NCT01929343Phase 2CompletedPrimary

Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving

NCT03025321Not ApplicableCompletedPrimary

Effects of tDCS on Craving, Relapse and Cognitive Functions Among Patients With Cocaine Use Disorder

NCT01822587Phase 2CompletedPrimary

Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving

NCT02939352Early Phase 1Completed

The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

NCT00292136CompletedPrimary

Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study

NCT00865332WithdrawnPrimary

Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates

NCT02768441Early Phase 1CompletedPrimary

Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

NCT02626494Phase 4CompletedPrimary

Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction

NCT03018236Phase 4UnknownPrimary

Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.

NCT00626834Phase 1CompletedPrimary

Vigabatrin Ph 1 Cocaine Interaction Study

NCT02892851Not ApplicableUnknownPrimary

Deep Brain Stimulation of the Sub-Thalamic Nucleus to Treat Severe and Treatment-resistant Cocaine Addiction.

NCT01984177Completed

Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence

NCT01281202Phase 2CompletedPrimary

Vigabatrin for the Treatment of Cocaine Dependency

NCT01887366Phase 2CompletedPrimary

Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

NCT00586534Not ApplicableCompletedPrimary

Developing Computer Based Treatments for Addiction

Scroll to load more

Research Network

Activity Timeline